Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors

Background: COVID-19, a global pandemic caused by SARS-CoV-2 infection, has led researchers around the world to search for therapeutic agents for treatment of the disease. The main protease (MPro) of SARS-CoV-2 is one of the potential targets in the development of new drug compounds for the disease....

Full description

Bibliographic Details
Main Authors:	Mohammad Rizki Fadhil Pratama, Hadi Poerwono, Siswandono Siswodihardjo
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2020-11-01
Series:	Pharmaceutical Sciences
Subjects:	5-o-benzoylpinostrobin docking remdesivir sars-cov-2 main protease protease inhibitors
Online Access:	https://ps.tbzmed.ac.ir/PDF/ps-26-S63.pdf

Similar Items

Molecular docking of 5-o-benzoylpinostrobin derivatives from boesenbergia pandurata roxb. as anti-inflammatory
by: Anang Setyo Wiyono, et al.
Published: (2023-03-01)

The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm.f) Ness
by: Sukardiman, et al.
Published: (2020-01-01)

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
by: Daoud Safa, et al.
Published: (2021-06-01)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024-01-01)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
by: Ibrahim Khater, et al.
Published: (2021-09-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
by: Suwicha Patnin, et al.
Published: (2022-03-01)

Introducing a two‐dimensional graph of docking score difference vs. similarity of ligand‐receptor interactions
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2021-03-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022-10-01)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023-04-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations
by: Faez Iqbal Khan, et al.
Published: (2021-07-01)

Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
by: Razie Sabet, et al.
Published: (2021-06-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations
by: Frontiers Production Office
Published: (2022-09-01)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
by: Panthakarn Rangsinth, et al.
Published: (2021-03-01)

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
by: Márió Miczi, et al.
Published: (2020-12-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
by: Alejandro Llanes, et al.
Published: (2020-12-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
by: Lukas van de Sand, et al.
Published: (2021-04-01)

Computational approach towards the design of artemisinin–thymoquinone hybrids against main protease of SARS-COV-2
by: Victor Moreira de Oliveira, et al.
Published: (2021-09-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
by: Željko Reiner, et al.
Published: (2020-04-01)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
by: Vishma Pratap Sur, et al.
Published: (2021-10-01)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
by: Matthias Göhl, et al.
Published: (2022-07-01)

Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: Evidence from a computational investigation
by: Md. Chayan Ali, et al.
Published: (2022-04-01)

Synthesis of indole-based oxadiazoles and their interaction with bacterial peptidoglycan and SARS-CoV-2 main protease: In vitro, molecular docking and in silico ADME/Tox study
by: Mohammad Azam Ansari, et al.
Published: (2022-05-01)

Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
by: Naike Ye, et al.
Published: (2021-09-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

A suitable drug structure for interaction with SARS‐CoV‐2 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study
by: Mehdi Yoosefian, et al.
Published: (2023-09-01)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
by: Pandu Hariyono, et al.
Published: (2022-01-01)

Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2
by: Anthi Petrou, et al.
Published: (2022-03-01)

In silico analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease
by: Saric Belmina, et al.
Published: (2021-06-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)